The $20 bln Danish wind group’s shares sank amid a $9 bln rights issue linked to an ailing US project. Political turmoil is ...

Novo Nordisk, GSK and others need to replenish their pipelines to replace drugs coming off patent. In the past, buying a promising biotech required paying a 100% premium. But high interest rates and ...

The South Asian nation is open to cutting Russian oil purchases to reduce a 50% US import tariff but Donald Trump’s attacks will, in the long run, only make it double down on its multipolar foreign ...

To stop perceived bias from BofA and its peers against his supporters, President Trump wants ‘reputation’ axed from customer ...

Foxconn, formally known as Hon Hai Precision Industry, and fellow Taiwan-headquartered TECO want to become a one-stop shop for clients setting up large-scale AI data centres. The two are cementing the ...

The Italian bank’s CEO Alberto Nagel is trying to revive a merger with Banca Generali to fend off a takeover by rival MPS. He’ll need shareholders who failed to support the deal to back him, and his ...

Shares of Match Group, owner of hook-up app Tinder, have collapsed by 80% since their peak in 2021. Fatigued younger users ...

David Zaslav will run the HBO half of the $30 bln media empire after it splits from slumping TV networks. He was paid an ...

The $210 bln Ozempic maker spends less than rivals on developing new drugs. That’s a problem as upstarts challenge its ...

Since unveiling a $9 bln stock swap to buy computing power supplier Core Scientific, the buyer’s shares have tumbled 30%.

That's the combined toll Toyota and Honda expect from US levies this year. Their calculations, though, rest on shifting assumptions on dates, where non-Japan tariffs settle and other details. Fragile ...

Donald Trump doubled US levies on Indian imports to 50%. Even if New Delhi can halve that by stopping its purchases of ...